| Expression pattern: |
UP |
| Associated gene: |
FOXM1 |
| Associated microRNA: |
miR-7-5p |
| Biological function: |
Promotes lung cancer cell proliferation, invasion and glycolysis and inhibits apoptosis; propofol suppresses these malignancies partly by downregulating circ-ERBB2. circ-ERBB2 knockdown enhances propofol’s tumor-suppressive effect in vivo. |
| Molecular mechanism: |
ceRNA mechanism: circ-ERBB2 sponges miR-7-5p, relieving miR-7-5p-mediated repression of FOXM1; propofol decreases circ-ERBB2 to modulate the circ-ERBB2/miR-7-5p/FOXM1 axis. |
| Biological pathway or process: |
proliferation (promotes); invasion (promotes); apoptosis (inhibits); glycolysis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; RNase R Treatment; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Luciferase Reporter Assay; Western Blot; In Vivo Animal Model; Clinical Sample Validation; Bioinformatics Analysis |
| Clinical significance: |
- |
| Description: |
circ-ERBB2 is up-regulated in lung cancer tissues and cell lines, and propofol reduces its expression. Mechanistically, circ-ERBB2 sponges miR-7-5p to increase FOXM1, thereby promoting malignant phenotypes including proliferation, invasion and glycolysis and reducing apoptosis; circ-ERBB2 knockdown enhances propofol’s antitumor effects in xenografts. |
| Confidence score: |
0.742 |